Journal
PLANTA MEDICA
Volume 81, Issue 4, Pages 279-285Publisher
GEORG THIEME VERLAG KG
DOI: 10.1055/s-0034-1396241
Keywords
rhein; hyperuricemia; nephroprotective effect; xanthine oxidase; uricosuric action; interleukin-1 beta; transforming growth factor-beta 1
Categories
Funding
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Ask authors/readers for more resources
Hyperuricemia has been considered to be a key risk factor for kidney disease. The formation of uric acid crystals in the kidney further stimulates an intensive inflammatory response. Rhein possesses various pharmacological activities, including anti-inflammatory, antioxidative, antitumor, purgative effects, and so on. To our knowledge, no previous work has been reported about the therapeutic effect of rhein on urate nephropathy. In this study, a model of hyperuricemia and nephropathy induced by adenine and ethambutol in mice was established. Meanwhile, the potential beneficial effects and mechanisms of rhein on hyperuricemia and nephropathy were also investigated. The results demonstrated that rhein significantly decreased the serum uric acid level by inhibiting the xanthine oxidase activity and increasing the excretion of urinary uric acid. In addition, rhein also markedly improved kidney damage related to hyperuricemia. Further investigation indicated that rhein improved the symptoms of nephropathy through decreasing the production of proinflammatory cytokines, including interleukin 1 beta, prostaglandin E-2, and tumor necrosis factor-alpha and inhibiting the expression of transforming growth factor-beta 1. The present study suggests that rhein may have a considerable potential for development as an anti-hyperuricemic and nephroprotective agent for clinical application.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available